172 related articles for article (PubMed ID: 10472974)
1. Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck.
Mukherji SK; Gapany M; Phillips D; Neelon B; O'Brien S; McCartney W; Buejenovich S; Parekh JS; Noordzij JP; Castillo M
AJNR Am J Neuroradiol; 1999 Aug; 20(7):1215-20. PubMed ID: 10472974
[TBL] [Abstract][Full Text] [Related]
2. Occult primary tumors of the head and neck: accuracy of thallium 201 single-photon emission computed tomography and computed tomography and/or magnetic resonance imaging.
van Veen SA; Balm AJ; Valdés Olmos RA; Hoefnagel CA; Hilgers FJ; Tan IB; Pameijer FA
Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):406-11. PubMed ID: 11296049
[TBL] [Abstract][Full Text] [Related]
3. Thallium-201 SPECT in the diagnosis of head and neck cancer.
Valdés Olmos RA; Balm AJ; Hilgers FJ; Koops W; Loftus BM; Tan IB; Muller SH; Hoefnagel CA; Gregor RT
J Nucl Med; 1997 Jun; 38(6):873-9. PubMed ID: 9189132
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 201T1 SPECT for predicting early treatment response in patients with squamous cell carcinoma of the extracranial head and neck treated with nonsurgical organ preservation therapy: initial results.
Mukherji SK; Gapany M; Neelon B; McCartney W
J Comput Assist Tomogr; 2000; 24(1):146-51. PubMed ID: 10667674
[TBL] [Abstract][Full Text] [Related]
5. Thallum-201 single-proton emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck.
O'Tuama LA; Young Poussaint T
AJNR Am J Neuroradiol; 2001; 22(10):1983-4. PubMed ID: 11733339
[No Abstract] [Full Text] [Related]
6. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
[TBL] [Abstract][Full Text] [Related]
7. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
8. Comparison of thallium-201 SPET and CT/MRI in the detection of residual/recurrent squamous cell carcinoma of the oral cavity.
Lee JK; Tyan YS; Huang WS
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):528-31. PubMed ID: 14722682
[TBL] [Abstract][Full Text] [Related]
9. Comparison of thallium-201 and F-18 FDG SPECT uptake in squamous cell carcinoma of the head and neck.
Mukherji SK; Drane WE; Tart RP; Landau S; Mancuso AA
AJNR Am J Neuroradiol; 1994 Nov; 15(10):1837-42. PubMed ID: 7863932
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of single-photon emission computed tomography/computed tomography for sentinel lymph node localization in head and neck cutaneous malignancy.
Remenschneider AK; Dilger AE; Wang Y; Palmer EL; Scott JA; Emerick KS
Laryngoscope; 2015 Apr; 125(4):877-82. PubMed ID: 25388656
[TBL] [Abstract][Full Text] [Related]
11. Preliminary experience with thallous chloride T1 201-labeled single-photon emission computed tomography scanning in head and neck cancer.
Gregor RT; Valdés-Olmos R; Koops W; Balm AJ; Hilgers FJ; Hoefnagel CA
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):509-14. PubMed ID: 8615968
[TBL] [Abstract][Full Text] [Related]
12. Assessment of cervical lymph node metastasis with different imaging methods in patients with head and neck squamous cell carcinoma.
Akoğlu E; Dutipek M; Bekiş R; Değirmenci B; Ada E; Güneri A
J Otolaryngol; 2005 Dec; 34(6):384-94. PubMed ID: 16343398
[TBL] [Abstract][Full Text] [Related]
13. Correlative 201Tl SPECT, MRI and ex vivo 201Tl uptake in detecting and characterizing cervical lymphadenopathy in head and neck squamous cell carcinoma.
Valdés Olmos RA; Koops W; Loftus BM; Liem IH; Gregor RT; Hoefnagel CA; Hilgers FJ; Balm AJ
J Nucl Med; 1999 Sep; 40(9):1414-9. PubMed ID: 10492358
[TBL] [Abstract][Full Text] [Related]
14. Combined SPECT/CT improves detection of initial bone invasion and determination of resection margins in squamous cell carcinoma of the head and neck compared to conventional imaging modalities.
Kolk A; Schuster T; Chlebowski A; Lange P; Scheidhauer K; Kesting M; Bissinger O; Schwaiger M; Dinges J; Weitz J
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1363-74. PubMed ID: 24573657
[TBL] [Abstract][Full Text] [Related]
15. Utility of CT surveillance for primary site recurrence of squamous cell carcinoma of the head and neck.
Sullivan BP; Parks KA; Dean NR; Rosenthal EL; Carroll WR; Magnuson JS
Head Neck; 2011 Nov; 33(11):1547-50. PubMed ID: 21990217
[TBL] [Abstract][Full Text] [Related]
16. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of undifferentiated carcinoma of nasopharyngeal type with thallium-201 and technetium-99m MIBI SPECT.
Sobic-Saranovic DP; Pendjer IP; Kozarevic NDj; Artiko VM; Mikic AA; Obradovic VB
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):405-11. PubMed ID: 17765766
[TBL] [Abstract][Full Text] [Related]
18. [Role of positron emission tomography and CT with 18F-FDG PET-CT in follow-up of patients treated for head and neck squamous cell carcinoma].
Rivière D; Morvan JB; Fakhry N; Vatin L; Cathelinaud O; Bousquet F; Giovanni A; Verdalle P
Rev Laryngol Otol Rhinol (Bord); 2014; 135(3):127-33. PubMed ID: 26521355
[TBL] [Abstract][Full Text] [Related]
19. Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer.
McDermott M; Hughes M; Rath T; Johnson JT; Heron DE; Kubicek GJ; Kim SW; Ferris RL; Duvvuri U; Ohr JP; Branstetter BF
AJNR Am J Neuroradiol; 2013 Aug; 34(8):1632-6. PubMed ID: 23639557
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E
Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
